Abstract:
본 발명은 발광 특성을 갖는 나프토아크리딘 화합물에 관한 것으로서, 더욱 상세하게는 9 H -나프토[3,2,1- kl ]아크리딘을 모핵으로 하고 C9 위치에 다양한 방향족 또는 헤테로방향족 그룹이 치환되어 있는 신규 구조의 화합물로서, 자외선 또는 가시광선에 의해 발광하는 특성을 나타내므로 형광염료, 형광체, 또는 유기 전계발광소자나 디스플레이의 발광재료로 유용한 나프토아크리딘 화합물에 관한 것이다.
Abstract:
PURPOSE: A naphtoacridine compound is provided to be used as fluorescent or luminous dye, or to be used as fluorescent or luminous material for organic electroluminescence devices by having a property excited by a wavelength of UV rays or visible rays. CONSTITUTION: A naphtoacridine compound is in chemical formula 1. The naphtoacridine compound in chemical formula 1 is manufactured by witting reaction of 9H-naphtho[3,2,1-kl]acridin-9-one and triphenylphosphonium bromide in chemical formula 3. In the chemical formulas, R^1 and R^2 is the same or different each other, selected from a phenyl group, a biphenyl group, a naphthalene group, a pyridine group. The witting reaction is conducted with a base of C1-6 alkoxy alkali metal salt under the condition of inert condition.
Abstract:
PURPOSE: A novel pyrollo[3,2-b]pyridine derivative and a pharmaceutical composition for preventing or treating melanoma containing the same are provided to ensure high anti-proliferative activity to melanoma cells. CONSTITUTION: A pyrollo(3,2-b)pyridine derivative is denoted by chemical formula 1. A method for preparing the pirrolo(3,2,-b)pyridine derivative comprises: a step of coupling 1-iodine-4-nitrobenze to a compound of chemical formula 2 to obtain a compound of chemical formula 3; a step of reducing the compound of chemical formula 3 to obtain a compound of chemical formula 4; and a step of coupling the compound of chemical formula 4 with a phenylcarboxylic acid or amine derivative which trifluoromethyl, halogen, morpholine, piperazine. A pharmaceutical composition for preventing or treating melanoma contains the pyrollo(3,2-b)pyridine derivative or pharmaceutically acceptable salt as an active ingredient.
Abstract:
PURPOSE: A process for preparing Gallamine derivative is provided, thereby cheaply preparing the Gallamine derivative which is useful in synthesis of aminoglycoside antibiotics including isepamycin. CONSTITUTION: A process for preparing Gallamine derivative of the formula(4) comprises the steps of: introducing acetyl(-Ac) or benzyloxycarbonyl(-Cbz) into the amine group of 3,2',6'-NH2 of sisomicin or gentamicin to prepare a compound of the formula(1); reacting the amine group of 1-NH2 of the compound of the formula(1) with anhydride of acid represented by YOH or acid derivative thereof to prepare a compound of the formula(2); introducing acetyl(-Ac) or benzyloxycarbonyl(-Cbz) into the amine group of 3'-NH2 of the compound of the formula(2) to prepare a compound of the formula(3); and reacting the compound of the formula(3) under acid condition to remove purpurosamine or sisosamine ring to prepare the Gallamine derivative of the formula(4), wherein R1 and R2 are independently hydrogen or methyl; X is acetyl or benzyloxycarbonyl; Y is C1 to C10 alkylcarbonyl, or amino or hydroxy substituted C1 to C10 alkylcarbonyl.
Abstract:
PURPOSE: A method for preparing 2-acetylnicotinic acid is provided to improve the deoxygenating process, thereby reducing the environmental pollution and the manufacturing cost and enhancing production yield and purity. CONSTITUTION: The method comprises the steps of acetylating nicotinic acid N-oxide, deoxygenating the acetylated compound; and treating the deoxygenated compound with an alkali or acid aqueous solution to obtain 2-acetylnicotinic acid, wherein the deoxygenation is carried out by using an alcohol solvent and a Pd/C catalyst under the hydrogen gas atmosphere. Preferably the deoxygenation is carried out at 0.5-3 % Pd/C catalyst in alcohols and at a hydrogen gas pressure of 1-10 atm.
Abstract:
PURPOSE: A compound containing quinoxalicarbazole and an organic electric device using the same are provided to be used as a host material of a phosphor dopant of various colors. CONSTITUTION: An organic electric device contains one or more organic layers containing a compound containing quinoxalinocabazole of chemical formula 1. The organic electric device comprises a first electrode, one or more organic layers and second electrode. The organic layer includes a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and a light emitting layer. A terminal comprises a display device and a control unit.